Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 9.847% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CC(C)NC(=O)Cn1c(SCC(=O)N2CCCCCC2)nc2ccccc21
b. Cc1ccccc1C1c2[nH]c3ccccc3c2CCN1CCCn1cccn1
Answer: a. CC(C)NC(=O)Cn1c(SCC(=O)N2CCCCCC2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)NC(=O)Cn1c(SCC(=O)N2CCCCCC2)nc2ccccc21
CC(C)NC(=O)Cn1c(SCC(=O)N2CCCCCC2)nc2ccccc21
2-[2-[2-(azepan-1-yl)-2-oxoethyl]sulfanylbenzimidazol-1-yl]-N-propan-2-ylacetamide